John Alexander
Duke Clinical Research Institute · Steering Committee · Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John Alexander as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05785819 · A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced ThrombocytopeniaVeralox Therapeutics · terminated · Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia · study chair
- Ph3NCT04142658 · PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanArtivion Inc. · terminated · Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Failure · study chair
- Ph3NCT04045665 · Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGIcahn School of Medicine at Mount Sinai · recruiting · Atrial Fibrillation, Stroke, Bleeding · study director
- N/ANCT02881632 · Pneumacare SLP Validation in Infants and in Clinical BronchiolitisUniversity Hospitals of North Midlands NHS Trust · completed · Bronchiolitis · principal investigator
- Ph3NCT02663908 · A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseFerring Pharmaceuticals · terminated · Prostate Cancer · principal investigator
- N/ANCT02482779 · Smartphone Application-Based Vital Sign MonitorsUniversity of Texas Southwestern Medical Center · completed · Signs and Symptoms · principal investigator
- Ph3NCT02025621 · Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary BypassTenax Therapeutics, Inc. · completed · Coronary Artery Bypass Grafting, Mitral Valve Surgery, Low Cardiac Output Syndrome · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Increasing the Quality and Efficiency of Clinical Trials (U18)U18FD005292 · FDA · DUKE UNIVERSITY · fiscal years 2019 to 2026 · $2,999,999 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Network for Cardiothoracic Surgical Investigations in Cardiovascular MedicineU01HL088942 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Anne Christine Gelijns, ALAN J MOSKOWITZ · fiscal years 2007 to 2025Named on NCT04045665
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:28 UTC. The ranking covers the 200 most relevant of 442 PubMed records, and a shared surname and initials can bring in a namesake. All 442 on PubMed
- Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med · 20117,051 citationsRCR 232.6
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.N Engl J Med · 2019903 citationsRCR 42.2
- 829 citationsRCR 38.4
- Apixaban with antiplatelet therapy after acute coronary syndrome.N Engl J Med · 2011785 citationsRCR 21.5
- A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.N Engl J Med · 2008437 citationsRCR 15.1
- 428 citationsRCR 33.2
- Community education for cardiovascular health.Lancet · 1977408 citationsRCR 22.3
- Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.Am Heart J · 2010364 citationsRCR 9.8
- 337 citationsRCR 17.1
- Surgical treatment of moderate ischemic mitral regurgitation.N Engl J Med · 2014331 citationsRCR 10.4